Research & Development
Collaboration: Page 2
NanoString, Visiopharm collaborate on spatial imaging, machine learning for biomarker and drug target discovery
By leveraging their respective technologies, the companies aim to accelerate the discovery of biomarkers and drug targets, as well as enhance and validate high-plex spatial molecular data.
October 13, 2022
Oni, University of Pennsylvania to collaborate on CAR-T therapy research
Oni's Nanoimager super-resolution microscopy will allow researchers to visualize living cells and observe how single molecules interact.
October 11, 2022
Bio-Techne, Progen introduce new series of viral titer assays
The assays -- AAV1, AAV6, and AAV8 -- feature Progen’s antibody reagents, perform similarly to Progen’s AAV enzyme-linked immunoassays (ELISAs), and are part of the Ella immunoassay platform, Bio-Techne said.
October 11, 2022
Capitainer, University of Florida to develop quantitative dried blood spot-sampling technology
The collaboration aims to accelerate the development of necessary laboratory tools to address a shortage of clinical laboratories and methods for at-home collection of microsamples.
October 6, 2022
Guardian Research Network, Northeast Georgia Health partner on clinical research, patient treatment
GRN, whose activities include testing for early cancer diagnosis, said the collaboration aims to enable innovation in clinical research and patient treatment for local, rural, and suburban communities.
September 30, 2022
Epicore announces partnership with 3M and Innovize to scale portfolio of wearable hydration solutions
Wearable solutions developer Epicore Biosystems on Thursday announced a partnership with 3M’s Health Care Business and Innovize to scale the development of its sweat-sensing wearable technology.
September 29, 2022
Dr. Fauci invokes Yogi Berra to describe emerging infectious disease challenge
C2N Diagnostics launching next-generation blood test for Alzheimer's disease detection
Thermo Fisher Scientific introduces digital PCR liquid-biopsy assays for academic, clinical research
Thermo Fisher Scientific updates Applied Biosystems genetic analyzers to comply with IVDR
Aspira announces commercial launch of blood-based ovarian cancer risk assay
Sherlock Biosciences secures funding to further develop CRISPR testing platform
PathAI partners with Roche for AI tech
The companies said the partnership allows for broad access to digital pathology diagnostics to support clinical research and companion diagnostic programs globally.
October 14, 2021
MD Anderson, BostonGene enter into strategic alliance
The agreement expands upon existing research collaborations between BostonGene and multiple center researchers. MD Anderson and BostonGene will work together on clinical utility studies designed to support incorporating BostonGene testing into national guidelines and adoption as a national standard of care.
September 30, 2021
Group forms to evaluate early cancer detection tests
MCED tests use blood draws, urine, saliva, or stool samples to rapidly screen for multiple types of cancer at once, potentially catching and treating disease earlier. The consortium will evaluate the clinical and public health value of the tests for earlier cancer detection and treatment and establish standards for their use in routine medical care.
April 22, 2021
Study revises thinking on genes and breast cancer risk
The review incorporates the findings of the Cancer Risk Estimates Related to Susceptibility (CARRIERS) consortium, a group evaluating predisposition genes and the incidence of breast cancer. Drawing from U.S. population studies, researchers evaluated hereditary cancer genetic testing for 12 established breast cancer genes in a total of 32,247 women with breast cancer and 32,544 women without breast cancer. Results were published by Fergus Couch, PhD, a consultant in experimental pathology and laboratory medicine at the Mayo Clinic, and colleagues.
January 21, 2021
Pershing Square Foundation funds SARS-CoV-2 research
The researchers typically focus on cancer research but are instead using their expertise to better understand SARS-CoV-2, the virus that causes COVID-19. The winning projects include a variety of research topics related to COVID-19 and SARS-CoV-2, including potential treatments, genetic or immune determinants, and testing.
July 7, 2020
Is whole genome sequencing for children with rare diseases worth the price?
WGS has been proposed as a possible shortcut out of the "diagnostic odyssey," the ordeal endured by patients with rare diseases as they undergo a seemingly endless series of clinical evaluations, imaging studies, and laboratory tests before obtaining a diagnosis.
June 29, 2020
Page 2 of 3